These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14988633)

  • 1. The total artificial heart: where we stand.
    Frazier OH; Dowling RD; Gray LA; Shah NA; Pool T; Gregoric I
    Cardiology; 2004; 101(1-3):117-21. PubMed ID: 14988633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac prosthesis as an advanced surgical therapy for end-stage cardiac patients: current status and future perspectives.
    Takatani S
    J Med Dent Sci; 2000 Sep; 47(3):151-65. PubMed ID: 12160228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience with the AbioCor implantable replacement heart system.
    Dowling RD; Gray LA; Etoch SW; Laks H; Marelli D; Samuels L; Entwistle J; Couper G; Vlahakes GJ; Frazier OH
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):131-41. PubMed ID: 14752423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients.
    Roussel JC; Sénage T; Baron O; Périgaud C; Habash O; Rigal JC; Treilhaud M; Trochu JN; Despins P; Duveau D
    Ann Thorac Surg; 2009 Jan; 87(1):124-9; discussion 130. PubMed ID: 19101284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total artificial hearts: bridge to transplantation.
    Copeland JG; Arabia FA; Tsau PH; Nolan PE; McClellan D; Smith RG; Slepian MJ
    Cardiol Clin; 2003 Feb; 21(1):101-13. PubMed ID: 12790049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AbioCor totally implantable artificial heart. How will it impact hospitals?
    Health Devices; 2002 Sep; 31(9):332-41. PubMed ID: 12400223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Artificial heart].
    Nakatani T
    Kyobu Geka; 2007 May; 60(5):365-71. PubMed ID: 17515079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factor analysis for bridge to transplantation with the CardioWest total artificial heart.
    Copeland JG; Smith RG; Bose RK; Tsau PH; Nolan PE; Slepian MJ
    Ann Thorac Surg; 2008 May; 85(5):1639-44. PubMed ID: 18442554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total artificial heart freedom driver in a patient with end-stage biventricular heart failure.
    Friedline K; Hassinger P
    AANA J; 2012 Apr; 80(2):105-12. PubMed ID: 22586879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac replacement with a total artificial heart as a bridge to transplantation.
    Copeland JG; Smith RG; Arabia FA; Nolan PE; Sethi GK; Tsau PH; McClellan D; Slepian MJ;
    N Engl J Med; 2004 Aug; 351(9):859-67. PubMed ID: 15329423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total artificial heart.
    Sale SM; Smedira NG
    Best Pract Res Clin Anaesthesiol; 2012 Jun; 26(2):147-65. PubMed ID: 22910087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical therapy of end-stage heart failure. State of the art 2006].
    Klotz S; Loeher A; Drees G; Scheld HH
    Herz; 2006 Aug; 31(5):445-54. PubMed ID: 16944064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destination therapy with ventricular assist devices.
    Raman J; Jeevanadam V
    Cardiology; 2004; 101(1-3):104-10. PubMed ID: 14988631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with more than 100 total artificial heart implants.
    Copeland JG; Copeland H; Gustafson M; Mineburg N; Covington D; Smith RG; Friedman M
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):727-34. PubMed ID: 22245242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total artificial heart bridge to transplantation: a 9-year experience with 62 patients.
    Copeland JG; Smith RG; Arabia FA; Nolan PE; McClellan D; Tsau PH; Sethi GK; Bose RK; Banchy ME; Covington DL; Slepian MJ
    J Heart Lung Transplant; 2004 Jul; 23(7):823-31. PubMed ID: 15261176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New technologies for mechanical circulatory support: current status and future prospects of CorAide and MagScrew technologies.
    Fukamachi K
    J Artif Organs; 2004; 7(2):45-57. PubMed ID: 15309670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced heart failure: feasibility study of long-term continuous axial flow pump support.
    Siegenthaler MP; Westaby S; Frazier OH; Martin J; Banning A; Robson D; Pepper J; Poole-Wilson P; Beyersdorf F
    Eur Heart J; 2005 May; 26(10):1031-8. PubMed ID: 15800020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.